Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
European Urology Focus|April 29, 2023
Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical TrialsRano Matta, Refik Saskin, Sarah Neu, et al.Clinical Genitourinary Cancer|September 5, 2024
The Incidence of Extreme Serum Prostate Specific Antigen Levels During the COVID-19 PandemicAmanda E Hird, Rano Matta, Refik Saskin, et al.Therapeutic Advances in Urology|April 24, 2026
Endocannabinoid responses to relief of obstruction in acute injured kidney: a prospective observational studyAriel Rothner, Sharon E Fishberg, Liad Hinden, et al.Urology|May 6, 2022
National Trends and Outcomes in the Use of Intravesical Botulinum Toxin and Enterocystoplasty Among Patients With MyelomeningoceleRano Matta, Joshua J Horns, Deborah L Jacobson, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 12, 2018
The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancerAlaina Garbens, Christopher J D Wallis, Rano Matta, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2020
Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation modelAmanda E Hird, Diana E Magee, Douglas C Cheung, et al.Urology|July 16, 2023
Treatment Patterns in Men Prescribed Benign Prostatic Obstruction or Overactive Bladder Medications in Canada: A Retrospective Population-based StudySarah Neu, Rano Matta, Jennifer Locke, et al.Urology|October 14, 2023
Impact of Prostate Cancer-related Genitourinary Radiation Injury on Mental Health Diagnosis and Treatment: Assessment of 55,425 MenKevin Hebert, Ann Bruno, Rano Matta, et al.Urology|October 7, 2023
The Use of Metformin in Overactive Bladder: A Retrospective Nested Case-control, Population-based AnalysisSarah Neu, Rano Matta, Jennifer A Locke, et al.JAMA Network Open|March 9, 2026
Emergency Department Visits, Hospital Admissions, and Wait Times for Patients With Urologic ConditionsRano Matta, Jordyn Shaw, Hodan Mohamud, et al.Pageof 4